[{"Assets_0_Q3_USD":95468000.0,"CommonStockSharesOutstanding_0_Q3_shares":13369001.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-14798000.0,"NetIncomeLoss_1_Q3_USD":-8619000.0,"NetIncomeLoss_3_Q3_USD":-21845000.0,"StockholdersEquity_0_Q3_USD":76920000.0,"Ticker":"GEVO","CIK":"1392380","name":"GEVO, INC.","OfficialName":"Gevo Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"886730226.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20191113"}]